Evidence map›Paper›PMID 38107157›Full record

ArticleCanadian journal of kidney health and disease2023

Patient and Clinician Experiences With the Combination of Virtual and In-Person Chronic Kidney Disease Care Since the COVID-19 Pandemic.

Micheli Bevilacqua, Yuriy Melnyk, Helen Chiu, Janet Williams, Paul Watson, Brenda Lee, Palvir Dhariwal, Marlee McGuire, Julie Wei, Robin Chohan and 4 more

Open access · goldAbstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Micheli BevilacquaBC Renal, Vancouver, Canada.ORCID https://orcid.org/0000-0001-8321-7413
Yuriy MelnykBC Renal, Vancouver, Canada.
Helen ChiuBC Renal, Vancouver, Canada.
Janet WilliamsBC Renal, Vancouver, Canada.
Paul WatsonBC Renal, Vancouver, Canada.
Brenda LeeBC Renal, Vancouver, Canada.
Palvir DhariwalOffice of Virtual Health, Provincial Health Services Authority, Vancouver, BC, Canada.
Marlee McGuireOffice of Virtual Health, Provincial Health Services Authority, Vancouver, BC, Canada.ORCID https://orcid.org/0000-0001-9832-1854
Julie WeiOffice of Virtual Health, Provincial Health Services Authority, Vancouver, BC, Canada.
Robin ChohanOffice of Virtual Health, Provincial Health Services Authority, Vancouver, BC, Canada.
Anne LogieBC Renal, Vancouver, Canada.
Michele FryerOffice of Virtual Health, Provincial Health Services Authority, Vancouver, BC, Canada.
Dominik StollOffice of Virtual Health, Provincial Health Services Authority, Vancouver, BC, Canada.
Adeera LevinBC Renal, Vancouver, Canada.
Provincial Health Services Authority · CAUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Following onset of the COVID-19 pandemic, chronic kidney disease (CKD) clinics in BC shifted from established methods of mostly in-person care delivery to virtual care (VC) and thereafter a hybrid of the two. Objectives: To determine strengths, weaknesses, quality-of-care delivery, and key considerations associated with VC usage to inform optimal way(s) of integrating virtual and traditional methods of care delivery in multidisciplinary kidney clinics. Design: Qualitative evaluation. Setting: British Columbia, Canada. Participants: Patients and health care providers associated with multidisciplinary kidney care clinics. Methods: Development and delivery of semi-structured interviews of patients and health care providers. Results: 11 patients and/or caregivers and 12 health care providers participated in the interviews. Participants reported mixed experiences with VC usage. All participants foresaw a future where both VC and in-person care was offered. A reported benefit of VC was convenience for patients. Challenges identified with VC included difficulty establishing new therapeutic relationships, and variable of abilities of both patients and health care providers to engage and communicate in a virtual format. Participants noted a preference for in-person care for more complex situations. Four themes were identified as considerations when selecting between in-person and VC: person's nonmedical context, support available, clinical parameters and tasks to be completed, and clinic operations. Participants indicated that visit modality selection is an individualized and ongoing process involving the patient and their preferences which may change over time. Health care provider participants noted that new workflow challenges were created when using both VC and in-person care in the same clinic session. Limitations: Limited sample size in the setting of one-on-one interviews and use of convenience sampling which may result in missing perspectives, including those already facing challenges accessing care who could potentially be most disadvantaged by implementation of VC. Conclusions: A list of key considerations, aligned with quality care delivery was identified for health care providers and programs to consider as they continue to utilize VC and refine how best to use different visit modalities in different patient and clinical situations. Further work will be needed to validate these findings and evaluate clinical outcomes with the combination of virtual and traditional modes of care delivery. Trial registration: Not registered.

Indexed as

COVID-19multidisciplinary clinicteam-based caretelemedicinevirtual care

Identifiers

PMID38107157
PMCPMC10722955
OpenAlexW4389746105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.